Literature DB >> 24987871

Absence of pancreatic intraepithelial neoplasia predicts poor survival after resection of pancreatic cancer.

Benjamin G Hassid1, Aimee L Lucas, Marcela Salomao, Chunhua Weng, Feng Liu, Lauren G Khanna, Sheila Kumar, Caroline Hwang, John A Chabot, Harold Frucht.   

Abstract

OBJECTIVES: Pancreatic intraepithelial neoplasia (PanIN), thought to represent the dominant precursor of pancreatic adenocarcinoma (PDAC), is often found synchronously adjacent to resected PDAC tumors. However, its prognostic significance on outcome after PDAC resection is unknown.
METHODS: A total of 342 patients who underwent resection for PDAC between 2005 and 2010 at a single institution were identified and stratified according to highest grade of PanIN demonstrated surrounding the tumor. Clinical and pathologic characteristics of each patient and tissue were recorded and analyzed. The primary outcome was length of survival after resection.
RESULTS: An absence of PanIN lesions was identified in 32 patients (9%), low grade PanIN without synchronous high grade lesions was identified in 52 patients (15%), and high grade PanIN was found in 258 patients (75%). Median survival were 12.8 months for the non-PanIN group, 26.3 months for the low-grade PanIN group, and 23.8 months for the high-grade PanIN groups (P = 0.043). In multivariable analysis, absence of PanIN was independently associated with poor survival (P = 0.002).
CONCLUSIONS: The patients who demonstrate an absence of PanIN in the pancreatic tissue adjacent to the resected PDAC tumor have shorter postresection survival compared with those who demonstrate a PanIN lesion.

Entities:  

Mesh:

Year:  2014        PMID: 24987871      PMCID: PMC4161626          DOI: 10.1097/MPA.0000000000000161

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  31 in total

1.  K-ras mutation is an early event in pancreatic duct carcinogenesis in the Syrian golden hamster.

Authors:  W L Cerny; K A Mangold; D G Scarpelli
Journal:  Cancer Res       Date:  1992-08-15       Impact factor: 12.701

2.  Pancreatic cancer screening in a prospective cohort of high-risk patients: a comprehensive strategy of imaging and genetics.

Authors:  Elizabeth C Verna; Caroline Hwang; Peter D Stevens; Heidrun Rotterdam; Stavros N Stavropoulos; Carolyn D Sy; Martin A Prince; Wendy K Chung; Robert L Fine; John A Chabot; Harold Frucht
Journal:  Clin Cancer Res       Date:  2010-09-28       Impact factor: 12.531

Review 3.  Human correlates of provocative questions in pancreatic pathology.

Authors:  Oliver G McDonald; Anirban Maitra; Ralph H Hruban
Journal:  Adv Anat Pathol       Date:  2012-11       Impact factor: 3.875

4.  Prognostic factors associated with resectable adenocarcinoma of the head of the pancreas.

Authors:  K W Millikan; D J Deziel; J C Silverstein; T M Kanjo; J D Christein; A Doolas; R A Prinz
Journal:  Am Surg       Date:  1999-07       Impact factor: 0.688

5.  Increased Prevalence of Precursor Lesions in Familial Pancreatic Cancer Patients.

Authors:  Chanjuan Shi; Alison P Klein; Michael Goggins; Anirban Maitra; Marcia Canto; Syed Ali; Richard Schulick; Emily Palmisano; Ralph H Hruban
Journal:  Clin Cancer Res       Date:  2009-12-15       Impact factor: 12.531

Review 6.  Outcomes following resection of pancreatic cancer.

Authors:  Elan R Witkowski; Jillian K Smith; Jennifer F Tseng
Journal:  J Surg Oncol       Date:  2012-09-18       Impact factor: 3.454

Review 7.  Management strategies for patients with hereditary pancreatic cancer.

Authors:  Teresa A Brentnall
Journal:  Curr Treat Options Oncol       Date:  2005-09

8.  Distribution of intraductal lesions in small invasive ductal carcinoma of the pancreas.

Authors:  Takeshi Hisa; Koichi Suda; Bunsei Nobukawa; Hiroki Ohkubo; Satoshi Shiozawa; Hiroki Ishigame; Kenji Yamao; Yasushi Yatabe
Journal:  Pancreatology       Date:  2007-08-15       Impact factor: 3.996

9.  The impact of resection margin status and postoperative CA19-9 levels on survival and patterns of recurrence after postoperative high-dose radiotherapy with 5-FU-based concurrent chemotherapy for resectable pancreatic cancer.

Authors:  Timothy J Kinsella; Yuji Seo; Joseph Willis; Thomas A Stellato; Christopher T Siegel; Deborah Harpp; James K Willson; Joseph Gibbons; Juan R Sanabria; Jeffrey M Hardacre; James P Schulak
Journal:  Am J Clin Oncol       Date:  2008-10       Impact factor: 2.339

10.  Precursor lesions of early onset pancreatic cancer.

Authors:  Lukasz Liszka; Jacek Pająk; Sławomir Mrowiec; Ewa Zielińska-Pająk; Dariusz Gołka; Paweł Lampe
Journal:  Virchows Arch       Date:  2011-03-03       Impact factor: 4.064

View more
  6 in total

1.  Aggressive PDACs Show Hypomethylation of Repetitive Elements and the Execution of an Intrinsic IFN Program Linked to a Ductal Cell of Origin.

Authors:  Zuguang Gu; Charles D Imbusch; Martin R Sprick; Andreas Trumpp; Elisa Espinet; Nathalia A Giese; Magdalena Büscher; Mariam Safavi; Silke Weisenburger; Corinna Klein; Vanessa Vogel; Mattia Falcone; Jacob Insua-Rodríguez; Manuel Reitberger; Vera Thiel; Steffi O Kossi; Alexander Muckenhuber; Karnjit Sarai; Alex Y L Lee; Elyne Backx; Soheila Zarei; Matthias M Gaida; Manuel Rodríguez-Paredes; Elisa Donato; Hsi-Yu Yen; Roland Eils; Matthias Schlesner; Nicole Pfarr; Thilo Hackert; Christoph Plass; Benedikt Brors; Katja Steiger; Dieter Weichenhan; H Efsun Arda; Ilse Rooman; Janel L Kopp; Oliver Strobel; Wilko Weichert
Journal:  Cancer Discov       Date:  2020-10-15       Impact factor: 38.272

2.  Diversity of Precursor Lesions For Pancreatic Cancer: The Genetics and Biology of Intraductal Papillary Mucinous Neoplasm.

Authors:  Krushna C Patra; Nabeel Bardeesy; Yusuke Mizukami
Journal:  Clin Transl Gastroenterol       Date:  2017-04-06       Impact factor: 4.488

3.  Clinical significance of pancreatic intraepithelial neoplasia in resectable pancreatic cancer on survivals.

Authors:  Da-Young Yu; Young-Dong Yu; Wan-Bae Kim; Hyung-Joon Han; Sae-Byul Choi; Dong-Sik Kim; Sang-Yong Choi; Joo-Young Kim; Hyeyoon Chang; Baek-Hui Kim
Journal:  Ann Surg Treat Res       Date:  2018-04-30       Impact factor: 1.859

4.  Expression of SNAIL in accompanying PanIN is a key prognostic indicator in pancreatic ductal adenocarcinomas.

Authors:  Sho Fujiwara; Yuriko Saiki; Kota Ishizawa; Shinichi Fukushige; Mie Yamanaka; Masaki Sato; Masaharu Ishida; Fuyuhiko Motoi; Michiaki Unno; Akira Horii
Journal:  Cancer Med       Date:  2019-02-21       Impact factor: 4.452

5.  Metachronous pancreatic cancer originating from disseminated founder pancreatic intraductal neoplasias (PanINs).

Authors:  Koji Imai; Hidenori Karasaki; Yusuke Ono; Junpei Sasajima; Shin-Ichi Chiba; Hiroshi Funakoshi; Miho Muraki; Hideki Hanaoka; Takahisa Furukawa; Hiroyuki Furukawa; Toru Kono; Kazuo Nagashima; Yusuke Mizukami
Journal:  J Pathol Clin Res       Date:  2015-02-02

6.  Single-cell-resolved differentiation of human induced pluripotent stem cells into pancreatic duct-like organoids on a microwell chip.

Authors:  Sandra Wiedenmann; Markus Breunig; Jessica Merkle; Christine von Toerne; Tihomir Georgiev; Michel Moussus; Lucas Schulte; Thomas Seufferlein; Michael Sterr; Heiko Lickert; Stephanie Ellen Weissinger; Peter Möller; Stefanie M Hauck; Meike Hohwieler; Alexander Kleger; Matthias Meier
Journal:  Nat Biomed Eng       Date:  2021-07-08       Impact factor: 25.671

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.